OTCMKTS:RGIN Regenicin (RGIN) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free RGIN Stock Alerts $0.0050 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.0050▼$0.005050-Day Range N/A52-Week Range$0.0001▼$0.0050VolumeN/AAverage Volume6,769 shsMarket Capitalization$828,850.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Regenicin alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Regenicin Stock (OTCMKTS:RGIN)Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.Read More RGIN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RGIN Stock News HeadlinesApril 21, 2024 | americanbankingnews.comFinancial Contrast: Sensus Healthcare (NASDAQ:SRTS) and Regenicin (OTCMKTS:RGIN)January 20, 2024 | foxnews.comJohn Kerry praises Biden for preventing 'uncontrolled war in many regions'April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.December 9, 2023 | thestreet.comHistory of Walmart: Timeline and FactsAugust 22, 2023 | foxnews.comHeavy rains trigger floods and landslides in India's Himalayan region, leaving at least 48 deadJune 13, 2023 | bbc.comUkraine army attacks Russian forces in southern Zaporizhzhia regionJune 5, 2023 | fortune.comRegions FinancialApril 21, 2023 | reuters.comRussia's Promsvyazbank opening more branches in annexed regions of UkraineApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 11, 2023 | bbc.co.ukTundra regions of the worldMarch 28, 2023 | health.usnews.comRegions HospitalMarch 18, 2023 | news.yahoo.comDrought risk to England regions after dry February, scientists warnMarch 17, 2023 | fool.comRegions Bank Review: A Great Place for All-in-One BankingMarch 16, 2023 | usatoday.comNCAA Tournament South Region breakdown: Alabama clearly the favorite but championship pedigree lurksMarch 4, 2023 | bbc.co.ukWelsh rugby crisis: Regions braced to lose star names amid budget cutsMarch 4, 2023 | cbsnews.comCalifornia drought update: Winter storm lifts regions out of droughtFebruary 24, 2023 | skift.comSee What Regions of the World Are Fully Recovered: New Skift Travel Health IndexFebruary 18, 2023 | cbsnews.comDog flu cases on the rise in some U.S. regions this winter seasonFebruary 14, 2023 | usnews.comUkraine Says Three Major Regions Can Avoid Power Cuts After AttacksOctober 29, 2022 | reuters.comRGIN.PK - Regenicin Inc | Stock Price & Latest News | ReutersOctober 7, 2022 | reuters.comRussia's Federation Council ratifies annexation of four Ukrainian regionsOctober 4, 2022 | reuters.comRussian parliament to consider legal steps to absorb Ukrainian regionsSeptember 25, 2022 | marketwatch.comUkraine regions largely under control of Moscow-aligned separatists vote in referendums on joining RussiaSeptember 24, 2022 | theguardian.comFour occupied Ukraine regions plan imminent ‘votes’ on joining RussiaAugust 30, 2022 | ca.finance.yahoo.comThe Global Tissue Engineered Skin Substitutes Market grew USD 1,784.48 million by 2027, at a CAGR of 12.23%.February 11, 2022 | nasdaq.comRGIN Pre-Market QuotesSee More Headlines Receive RGIN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Regenicin and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/19/2020Today4/25/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:RGIN CUSIPN/A CIK1412659 Webwww.regenicin.com Phone(732) 757-5500FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-0.13Miscellaneous Outstanding Shares165,770,000Free FloatN/AMarket Cap$828,850.00 OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Randall E. McCoy (Age 75)Chairman, CEO & President Comp: $250kMr. John J. Weber (Age 74)CFO & Director Comp: $125kDr. J. Roy Nelson Ph.D. (Age 76)Controller & Chief Science Officer Comp: $150kKey CompetitorsSintx TechnologiesNASDAQ:SINTQHSLabOTCMKTS:USAQH-CYTEOTCMKTS:HCYTDMotus GINASDAQ:MOTSQuantRx BiomedicalOTCMKTS:QTXBView All Competitors RGIN Stock Analysis - Frequently Asked Questions How have RGIN shares performed in 2024? Regenicin's stock was trading at $0.0001 on January 1st, 2024. Since then, RGIN shares have increased by 4,900.0% and is now trading at $0.0050. View the best growth stocks for 2024 here. How were Regenicin's earnings last quarter? Regenicin, Inc. (OTCMKTS:RGIN) released its earnings results on Wednesday, August, 19th. The company reported $0.00 earnings per share for the quarter. What other stocks do shareholders of Regenicin own? Based on aggregate information from My MarketBeat watchlists, some companies that other Regenicin investors own include Energous (WATT), Vital Therapies (VTL), Xerox (XRX), Allergan (AGN), Leafbuyer Technologies (LBUY), (ZINCQ) (ZINCQ), Ambarella (AMBA) and Alstom (ALO). How do I buy shares of Regenicin? Shares of RGIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RGIN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regenicin, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
